176 related articles for article (PubMed ID: 30551199)
1. The Effect of Prostaglandin Analogue Bimatoprost on Thyroid-Associated Orbitopathy.
Choi CJ; Tao W; Doddapaneni R; Acosta-Torres Z; Blessing NW; Lee BW; Pelaez D; Wester ST
Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5912-5923. PubMed ID: 30551199
[TBL] [Abstract][Full Text] [Related]
2. In Vivo Effects of Retrobulbar Bimatoprost Injection on Orbital Fat.
Eftekhari K; Vagefi MR; Lee V; Hui JZ; Zhu M; Dine K; Anderson RL; Koeberlein B; Sulaimankutty R; Shindler KS
Ophthalmic Plast Reconstr Surg; 2018; 34(3):201-204. PubMed ID: 28369019
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor 1 promotes the proliferation and adipogenesis of orbital adipose-derived stromal cells in thyroid-associated ophthalmopathy.
Zhao P; Deng Y; Gu P; Wang Y; Zhou H; Hu Y; Chen P; Fan X
Exp Eye Res; 2013 Feb; 107():65-73. PubMed ID: 23219871
[TBL] [Abstract][Full Text] [Related]
4. In Vivo Effects of Prostaglandin Analogues Application by Topical Drops or Retrobulbar Injections on the Orbital Fat of a Rat Model.
Jbara D; Eiger-Moscovich M; Didkovsky E; Keshet Y; Avisar I
Ocul Immunol Inflamm; 2023 Feb; 31(2):298-303. PubMed ID: 35081015
[TBL] [Abstract][Full Text] [Related]
5. RNA-Sequencing Gene Expression Profiling of Orbital Adipose-Derived Stem Cell Population Implicate HOX Genes and WNT Signaling Dysregulation in the Pathogenesis of Thyroid-Associated Orbitopathy.
Tao W; Ayala-Haedo JA; Field MG; Pelaez D; Wester ST
Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6146-6158. PubMed ID: 29214313
[TBL] [Abstract][Full Text] [Related]
6. Integrating Differential Gene Expression Analysis with Perturbagen-Response Signatures May Identify Novel Therapies for Thyroid-Associated Orbitopathy.
Lee JY; Gallo RA; Ledon PJ; Tao W; Tse DT; Pelaez D; Wester ST
Transl Vis Sci Technol; 2020 Aug; 9(9):39. PubMed ID: 32908802
[TBL] [Abstract][Full Text] [Related]
7. Depot-specific characteristics of adipose tissue-derived stromal cells in thyroid-associated orbitopathy.
Wong JSC; Chu WK; Li BF; Pang CP; Chong KK
Br J Ophthalmol; 2018 Aug; 102(8):1173-1178. PubMed ID: 29666119
[TBL] [Abstract][Full Text] [Related]
8. Chitosan inhibits inflammation and adipogenesis of orbital fibroblasts in Graves ophthalmopathy.
Xiong H; Wu M; Zou H; Jiang S; Yi H; Yi T; Wang Q; Liu D; Zhou Y; Wei C; Zhou X
Mol Vis; 2018; 24():509-517. PubMed ID: 30090014
[TBL] [Abstract][Full Text] [Related]
9. Proteomics of Orbital Tissue in Thyroid-Associated Orbitopathy.
Matheis N; Lantz M; Grus FH; Ponto KA; Wolters D; Brorson H; Planck T; Shahida B; Pitz S; Pfeiffer N; Kahaly GJ
J Clin Endocrinol Metab; 2015 Dec; 100(12):E1523-30. PubMed ID: 26451909
[TBL] [Abstract][Full Text] [Related]
10. Octreotide inhibits secretion of IGF-1 from orbital fibroblasts in patients with thyroid-associated ophthalmopathy via inhibition of the NF-κB pathway.
Kim SE; Kim J; Lee JY; Lee SB; Paik JS; Yang SW
PLoS One; 2021; 16(4):e0249988. PubMed ID: 33886620
[TBL] [Abstract][Full Text] [Related]
11. The role of 11beta-hydroxysteroid dehydrogenase 1 in adipogenesis in thyroid-associated ophthalmopathy.
Tomlinson JW; Durrani OM; Bujalska IJ; Gathercole LL; Tomlins PJ; Reuser TT; Rose GE; Curnow SJ; Stewart PM; Walker EA; Rauz S
J Clin Endocrinol Metab; 2010 Jan; 95(1):398-406. PubMed ID: 19880789
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid induces COX-2 expression via CD44 in orbital fibroblasts from patients with thyroid-associated ophthalmopathy.
Lim HS; Back KO; Kim HJ; Choi YH; Park YM; Kook KH
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7441-50. PubMed ID: 25342622
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomic Profiling of Control and Thyroid-Associated Orbitopathy (TAO) Orbital Fat and TAO Orbital Fibroblasts Undergoing Adipogenesis.
Kim DW; Taneja K; Hoang T; Santiago CP; McCulley TJ; Merbs SL; Mahoney NR; Blackshaw S; Rajaii F
Invest Ophthalmol Vis Sci; 2021 Jul; 62(9):24. PubMed ID: 34269815
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory Effect of Idelalisib, a Selective Phosphatidylinositol 3-Kinase δ Inhibitor, on Adipogenesis in an In Vitro Model of Graves' Orbitopathy.
Ko J; Kim JY; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4477-4485. PubMed ID: 30193323
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin F2α and EP2 agonists, and a ROCK inhibitor modulate the formation of 3D organoids of Grave's orbitopathy related human orbital fibroblasts.
Ichioka H; Ida Y; Watanabe M; Ohguro H; Hikage F
Exp Eye Res; 2021 Apr; 205():108489. PubMed ID: 33587909
[TBL] [Abstract][Full Text] [Related]
16. Effect of retrobulbar prostaglandin analog injection on orbital fat in rats.
Cosan S; İnam O; Kaya B; Atilla P; Ocal O; Arat A; Karakaya J; Arat YO
Int Ophthalmol; 2023 Dec; 43(12):4985-4990. PubMed ID: 37847476
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin F2-Alpha Eye Drops (Bimatoprost) in Graves' Orbitopathy: A Randomized Controlled Double-Masked Crossover Trial (BIMA Trial).
Draman MS; Morris DS; Evans S; Haridas A; Pell J; Greenwood R; Foy C; Taylor P; Pooprasert P; Muller I; Zhang L; Lane C; Okosieme O; Ludgate M; Dayan C
Thyroid; 2019 Apr; 29(4):563-572. PubMed ID: 30880626
[TBL] [Abstract][Full Text] [Related]
18. Differentially expressed genes in orbital adipose/connective tissue of thyroid-associated orbitopathy.
Wang Y; Liu Y; Cai J; Zong T; Zhang Z; Xie T; Mu T; Wu M; Yang Q; Wang Y; Wang X; Yao Y
PeerJ; 2023; 11():e16569. PubMed ID: 38130930
[TBL] [Abstract][Full Text] [Related]
19. CD40 ligand induces expression of vascular cell adhesion molecule 1 and E-selectin in orbital fibroblasts from patients with Graves' orbitopathy.
Wang H; Zhu LS; Cheng JW; Cai JP; Li Y; Ma XY; Wei RL
Graefes Arch Clin Exp Ophthalmol; 2015 Apr; 253(4):573-82. PubMed ID: 25576172
[TBL] [Abstract][Full Text] [Related]
20. Bimatoprost protects retinal neuronal damage via Akt pathway.
Takano N; Tsuruma K; Ohno Y; Shimazawa M; Hara H
Eur J Pharmacol; 2013 Feb; 702(1-3):56-61. PubMed ID: 23395963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
